I recently came across this publication that got my attention. “Crisis management in the community mass recall of angiotensin II receptor blocker losartan due to nitrosamine impurities” by
Free Access: https://journals.sagepub.com/doi/10.1177/20101058221129715
The publication illustrates clearly the impact of Nitrosamines Impurities beyond the development/manufacturing space.
